Patents by Inventor Satishkumar Gadhiya

Satishkumar Gadhiya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF RHO-ASSOCIATED COILED-COIL KINASE
    Publication number: 20230295131
    Abstract: The present disclosure provides compounds of Formula (I); or a pharmaceutically acceptable salt thereof, wherein each of Ring A, Ring B, Ra, Rb, L, R1, R2, m, and n is defined herein, pharmaceutical compositions thereof, methods of inhibiting ROCK1 and/or ROCK2, and methods of treating a ROCK1- and/or ROCK2-mediated disease or disorder.
    Type: Application
    Filed: July 20, 2021
    Publication date: September 21, 2023
    Inventors: An-Hu Li, Shashikanth Ponnala, Satish Kumar Sakilam, Satishkumar Gadhiya, Yao Zong, Dong Sung Lim, Ying Zhang, Dawoon Jung
  • Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors
    Patent number: 11542256
    Abstract: The present invention provides compounds having formula (I): and pharmaceutically acceptable salts thereof, wherein Cy1, Cy2, Cy3, R, R1, R2, R3, A1 and A2 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which inhibiting ROCK1, ROCK2, or ROCK1/2 has a therapeutically useful role.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: January 3, 2023
    Assignee: Angion Biomedica Corp.
    Inventors: An-Hu Li, Dibyendu Dana, Dong Sung Lim, Satishkumar Gadhiya, Dawoon Jung, Prakash Narayan, Quaisar Ali, Swarnalatha Paka, Itzhak D. Goldberg
  • ETHYNYLHETEROCYCLES AS RHO-ASSOCIATED COILED-COIL KINASE (ROCK) INHIBITORS
    Publication number: 20220281841
    Abstract: The present invention provides compounds having formula (I): and pharmaceutically acceptable salts thereof, wherein Cy1, Cy2, Cy3, R, R1, R2, and R3 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which inhibiting ROCK1, ROCK2, or ROCK1/2 has a therapeutically useful role.
    Type: Application
    Filed: July 21, 2020
    Publication date: September 8, 2022
    Inventors: An-Hu Li, Satish Kumar Sakilam, Satishkumar Gadhiya, Dong Sung Lim, Yao Zong, Shashikanth Ponnala, Ying Zhang, Dawoon Jung, Lambertus J.W.M. Oehlen
  • VINYLHETEROCYCLES AS RHO-ASSOCIATED COILED-COIL KINASE (ROCK) INHIBITORS
    Publication number: 20200231576
    Abstract: The present invention provides compounds having formula (I): and pharmaceutically acceptable salts thereof, wherein Cy1, Cy2, Cy3, R, R1, R2, R3, A1 and A2 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which inhibiting ROCK1, ROCK2, or ROCK1/2 has a therapeutically useful role.
    Type: Application
    Filed: August 31, 2018
    Publication date: July 23, 2020
    Inventors: An-Hu Li, Dibyendu Dana, Dong Sung Lim, Satishkumar Gadhiya, Dawoon Jung, Prakash Narayan, Quaisar Ali, Latha Paka, Itzhak D. Goldberg